Despite treatment guidelines in place since 2005, non-occupational post-exposure HIV prophylaxis (nPEP) remains an underutilized prevention strategy. We conducted a retrospective chart review of patients presenting to a publicly-funded HIV clinic in Seattle, Washington for nPEP between 2000 and 2010 (N = 360). nPEP prescriptions were provided for 324 (90%) patients; 83 % of prescription decisions were appropriate according to Centers for Disease Control and Prevention guidelines, but only 31 % (N = 111/360) of patients were considered ‘‘high risk.’ ’ In order to use limited resources most efficiently, public health agencies should target messaging for this high-cost intervention to individuals with high-risk HIV exposures
BackgroundNonoccupational postexposure prophylaxis (nPEP) is a 28-day regimen of antiretroviral medi...
Since late 2001, the Department of Health (DOH) has monitored provision of nonoccupational post-expo...
Pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate in combination with emtricitabine...
Despite treatment guidelines in place since 2005, non-occupational post-exposure HIV prophylaxis (nP...
Non-occupational post-exposure prophylaxis (nPEP) use is an HIV prevention strategy that has been re...
BACKGROUND: We conducted a retrospective analysis of administration of nonoccupational HIV post-expo...
Objective: To review the evidence on the clinical effectiveness and cost-effectiveness of non-occupa...
BACKGROUND: In May 2005, the Western Australian Department of Health (WA Health) developed a communi...
The CDC recently released updated guidelines for the use of antiretroviral postexposure prophylaxis ...
OBJECTIVES: To review the evidence on the clinical effectiveness and cost-effectiveness of non-occup...
We conducted a retrospective analysis of data from a prospective nPEP (non-Occupational Post Exposur...
Since 2005, the CDC has published non-occupational post-exposure prophylaxis (nPEP) guidelines, yet ...
NewYork State (NYS) established guidelines for nonoccupational post-exposureprophylaxis (nPEP) toHIV...
We conducted a retrospective analysis of data from a prospective nPEP (non-Occupational Post Exposur...
OBJECTIVE: HIV-1 post-exposure prophylaxis (PEP) is frequently prescribed after exposure to source p...
BackgroundNonoccupational postexposure prophylaxis (nPEP) is a 28-day regimen of antiretroviral medi...
Since late 2001, the Department of Health (DOH) has monitored provision of nonoccupational post-expo...
Pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate in combination with emtricitabine...
Despite treatment guidelines in place since 2005, non-occupational post-exposure HIV prophylaxis (nP...
Non-occupational post-exposure prophylaxis (nPEP) use is an HIV prevention strategy that has been re...
BACKGROUND: We conducted a retrospective analysis of administration of nonoccupational HIV post-expo...
Objective: To review the evidence on the clinical effectiveness and cost-effectiveness of non-occupa...
BACKGROUND: In May 2005, the Western Australian Department of Health (WA Health) developed a communi...
The CDC recently released updated guidelines for the use of antiretroviral postexposure prophylaxis ...
OBJECTIVES: To review the evidence on the clinical effectiveness and cost-effectiveness of non-occup...
We conducted a retrospective analysis of data from a prospective nPEP (non-Occupational Post Exposur...
Since 2005, the CDC has published non-occupational post-exposure prophylaxis (nPEP) guidelines, yet ...
NewYork State (NYS) established guidelines for nonoccupational post-exposureprophylaxis (nPEP) toHIV...
We conducted a retrospective analysis of data from a prospective nPEP (non-Occupational Post Exposur...
OBJECTIVE: HIV-1 post-exposure prophylaxis (PEP) is frequently prescribed after exposure to source p...
BackgroundNonoccupational postexposure prophylaxis (nPEP) is a 28-day regimen of antiretroviral medi...
Since late 2001, the Department of Health (DOH) has monitored provision of nonoccupational post-expo...
Pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate in combination with emtricitabine...